GENE ONLINE|News &
Opinion
Blog

Cas9
Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
2021-04-01
New Cas9 Alternatives Give Mammoth Biosciences an Edge Over Other CRISPR companies
2020-10-25
CRISPR Pioneers Bag 2020 Nobel Prize in Chemistry
2020-10-07
Scientists Further Powerful Gene Editing Tech’s Caliber with Rapid, Low Cost COVID-19 Diagnosis
2020-09-06
Spotlight: New Hypercompact Megaphage Cas Enzyme (CasΦ) Shows Efficient Gene Editing
2020-08-16
CRISPR C-to-G Base Editors: A Therapeutic Promise
2020-07-31
Verve Therapeutic’s One Time Base Editing Treatment Cuts Down Cholesterol Levels in Blood
2020-06-30
Evolved Cas9 Facilitates CRISPR Access to Previously Unexplored Genomic Sites
2020-03-31
Jennifer Doudna Cofounded Mammoth Biosciences Bags $45M for CRISPR Based Diagnostics
2020-02-01
Broad Institute and Cyrus Biotech Join Hands to Develop Safe CRISPR
2019-12-05
Ignavibacterium Cas9 Beats Thermostability Record, Functions at 100 Degree Celsius
2019-11-14
The CRISPR-Cas9 Report Card
2018-06-14
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top